Phentolamine

Note: This product is not licenced in Australia at the time of publication. The information in this monograph applies to the specified brand, formulation and strength only.

Trade name

Fentanor

Strength

10 mg/mL (volume: 1 mL)

IV administration

Give undiluted as a rapid injection or dilute to a convenient volume for infusion.

Other routes of administration

IM: Suitable. Give undiluted.

SC: Not recommended.

Intradermal: For extravasation management. Dilute to 0.5 mg/mL and give 4 to 5 small aliquots by intradermal injection across the site of injury. Use within 12 hours of injury. Refer to local guidelines.

Compatible IV fluids

Sodium chloride 0.9%

Y-site only and phentolamine 5 mg/mL or weaker:

Potassium chloride 20 mmol/L

Additional information

Monitor blood pressure and administer while the patient is lying down.

Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.

Contains sulfites; may cause anaphylactic or asthmatic reactions in susceptible patients.

Refrigerate, do not freeze.